Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Humanoid Global Provides Portfolio Overview
-
Pan Cancer T Secures EUR 10 Million to Advance First-in-Human Trial of Novel TCR-T Cell Therapy for Triple-Negative Breast Cancer
-
IPinfo Reveals VPN Infrastructure Geolocation Mismatches in New Report
-
Danske Bank share buy-back programme: transactions in week 49
-
Geneva College of Longevity Science and DrVibe.ai Launch the GCLS AI Academy for Longevity Sciences
-
Transactions in connection with share buyback programme
-
Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program
-
Harder Digital secures new €25 million orders from major defence companies
-
EBC Financial Group Recognised as Best Broker for Execution at Professional Trader Awards 2025
-
Alm. Brand A/S – Weekly report on share buybacks
-
Festi hf.: Buyback program week 49
-
Eimskip: Transaction in relation to a share buy-back program
-
Scandinavian Tobacco Group A/S: Financial Calendar 2026
-
Prepayments, Realkredit Danmark A/S
-
FRO – 2025 Annual General Meeting
-
Varco Energy and Fluence Advance 142.5 MW Sizing John Energy Storage Project: Phase 1 Fully Operational, Launch of Phase 2
-
Aktsiaselts Infortar own share acquisition transactions
-
VEON’s Beeline Kazakhstan Breaks Ground for Hyper Cloud Data Center to Offer Sovereign Enterprise, AI and Digital Services
-
Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows
-
Ophævelse af suspension
-
The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki
-
Share buyback programme - week 49
-
Sidetrade Demonstrates Industry-Leading ESG Performance with EthiFinance Gold and EcoVadis Advanced Rating
-
WORLDLINE : PaymentIQ disposal - Press release
-
European Commission selects Capgemini for its EU cybersecurity framework contract
-
Share repurchase programme: Transactions of week 49 2025
-
Amphista Therapeutics presents new preclinical data showing the potential of its BRD9 Targeted Glue™, AMX-883, to transform the treatment paradigm for acute myeloid leukaemia
-
Diodon Drone, participation of Tonner Drones, accelerates its growth
-
Global Matrix Group (NASDAQ: GMGI) Appoints Mr William Scott to Build on Success and Accelerate Growth
-
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
-
Bowman Acquires RPT Alliance, Broadens Energy Engineering to Include Utility-Scale Power Generation for Data Centers and Industrial Facilities
-
Pulsar Helium Reports Pressurised Gas Encounter at Jetstream #5 and Down-Hole Testing Conducted at Jetstream #3 and #4
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 1)
-
ING reports outcome of 2025 EU-wide transparency exercise
-
Scatec signs equity partnership agreements for Obelisk in Egypt
-
Extension of charter agreement of the cruise ferry Silja Europa
-
Contract with Czechoslovak Group and positive investor feedback at the WOOD & Co Conference
-
Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
-
FIRST PATIENT DOSED IN CITRYLL’S PHASE IIA HIDRADENITIS SUPPURATIVA TRIAL
-
NBPE Announces Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
Transaction in Own Shares
-
SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS
-
Initial admission to the Official List
-
AI Agents to Power 1,000% More Customer Interactions for Enterprises Globally by 2027
-
Galapagos Presented New ATALANTA-1 Cell Therapy Data in MCL at ASH 2025
-
ASH 2025: Cellectis Presents Development Plan to Further Enhance High Response Rate Observed for Eti-cel in r/r NHL
-
OSE Immunotherapeutics Announces Strategic Amendment to AbbVie’s Partnership on ABBV-230 Development
-
Sampo plc’s share buybacks 5 December 2025
-
L’ORÉAL GROUPE TO REINFORCE ITS STRATEGIC INVESTMENT IN GALDERMA WITH AN ADDITIONAL 10% BRINGING ITS TOTAL PARTICIPATION TO 20%
